{"id":"dipiperonylaminoethanol","rwe":[],"tags":[{"label":"dipiperonylaminoethanol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"N05CX06","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"2-dipiperonylaminoethanol","offLabel":[],"synonyms":["dipiperonylaminoethanol","2-Dipiperonylaminoethanol"],"timeline":[],"approvals":[],"brandName":"2-Dipiperonylaminoethanol","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"dipiperonylaminoethanol","explanation":"Imagine your body's cells have locks on them, and the key to unlocking these locks is a specific shape that only fits one way. 2-Dipiperonylaminoethanol is thought to be this key, but we don't know which lock it opens or how it works once inside. This is a simplified explanation of how a drug like 2-Dipiperonylaminoethanol might work, but the actual process is much more complex and not yet fully understood.","oneSentence":"The exact mechanism of action of 2-Dipiperonylaminoethanol is unknown, but it is believed to interact with a specific biological target to produce its effects.","technicalDetail":"The technical details of 2-Dipiperonylaminoethanol's mechanism of action are currently unknown, and further research is needed to elucidate its pharmacological properties and potential therapeutic applications."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4772","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dipiperonylaminoethanol","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:41:41.852572","biosimilars":[],"competitors":[{"drugName":"meprobamate","drugSlug":"meprobamate","fdaApproval":"1955-04-28","genericCount":28,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"dipiperonylaminoethanol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"meprobamate","brandName":"meprobamate","genericName":"meprobamate","approvalYear":"1955","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"4X6T28A49X","CHEBI":"CHEBI:136030","PUBCHEM_CID":"57465308"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"N05CX06","allCodes":["N05CX06"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"2-Dipiperonylaminoethanol (dipiperonylaminoethanol) is a small molecule drug of unknown target and mechanism of action. Its commercial status and approved indications are currently unknown. As a dipiperonylaminoethanol, it is a member of a specific drug class, but further information is not available. Further research is needed to understand its potential therapeutic applications and safety profile. Its development and ownership history are also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}